DocGo's Q2 2026 earnings call transcript reveals a definitive agreement to acquire Hicuity Health, marking its largest acquisition to date, alongside record volumes in key business verticals. While Q2 revenue declined due to migrant project wind-down, non-migrant revenue grew, and adjusted EBITDA loss improved, indicating a strategic shift and focus on future growth and efficiency.
DocGo announced a definitive agreement to acquire Hicuity Health, a virtual care provider, which is its largest acquisition to date. This is a significant corporate catalyst as it is expected to create cost synergies, operational efficiencies, and contribute $65 million in revenue and $4.5 million in adjusted EBITDA, signaling a strong growth trajectory. While Q2 2026 revenue saw a decline due to the wind-down of migrant-related projects, non-migrant revenues increased by 19%, and adjusted EBITDA loss improved by 40% quarter-over-quarter, indicating effective cost management and a successful pivot. This acquisition and financial performance suggest a positive long-term outlook for DocGo, focusing on becoming a tech-powered healthcare delivery platform, offering cross-selling opportunities and enhancing efficiency through AI. Traders should note the short-term revenue dip but focus on the long-term strategic growth and profitability potential driven by the acquisition and efficiency initiatives.